Daytime Bright Light Exposure May Reduce Dementia Risk, Study Finds

Regular exposure to bright daytime light could significantly lower the risk of developing dementia, according to findings from a large prospective study of over 87,000 adults in the U.K. Biobank. Researchers found that individuals with an average daytime light exposure exceeding 1,000 lux—approximately equivalent to an overcast day—experienced a 16% reduced risk of dementia over an 8-year follow-up period (HR 0.84, 95% CI 0.71-0.99, P=0.039).

Furthermore, participants exposed to light levels of at least 5,000 lux for a minimum of 42 minutes daily showed an even stronger protective effect, with a 17% lower dementia risk (HR 0.83, 95% CI 0.70-0.99, P=0.036). The study, published in General Psychiatry, highlighted that this association remained robust even after adjusting for traditional risk factors such as obesity, alcohol consumption, and head trauma.

The research team, led by Dr. Hongliang Feng of Guangzhou Medical University, noted that the protective impact was especially pronounced among high-risk groups, including evening chronotypes (night owls), individuals with elevated nighttime light exposure, and carriers of the APOE4 gene variant, which is linked to Alzheimer’s disease. In these subgroups, light exposure correlated with a risk reduction of up to 41%.

Exploratory analyses suggested that circadian rhythm regulation may partially explain the link. Stabilization of rest-activity cycles and preservation of brain regions such as the fusiform cortex accounted for up to 33% of the observed risk reduction. Notably, vitamin D levels did not mediate the effect, indicating that the cognitive benefits arise directly from neural and circadian mechanisms rather than sunlight-induced vitamin D synthesis.

The study utilized wrist-worn accelerometers to measure light exposure over seven days, a methodological strength that captured real-world behavioral patterns. Over a median follow-up of 8.1 years, 741 participants developed dementia. However, the researchers acknowledged limitations, including the relatively homogeneous socioeconomic background of U.K. Biobank participants and the short-term nature of light exposure measurements.

“This is the largest cohort study to date linking objective daytime light exposure to dementia prevention in the general population,” Dr. Feng emphasized. “For clinicians, advocating routine bright light exposure during the day is a safe, cost-free strategy to support cognitive health, particularly in at-risk populations.” Preclinical evidence also suggests bright light may reduce neuroinflammation and slow amyloid-beta plaque formation, both hallmarks of Alzheimer’s disease.

Source link